DEV ENVIRONMENT — dev.library.globalcastmd.com — Changes here do not affect production
1 Views
0 Likes
0 Shares
0 Comments
Read article ↗

StayCurrentMD

View profile →

Article

The postoperative renal function of persistent cloaca patients treated by posterior sagittal anorecto-urethro-vaginopalsty: results of a nationwide survey in Japan

Published: Reading: 1 min

Topic overview

Nationwide Japanese study of 103 persistent cloaca patients post-PSARUVP found 45.6% developed reduced renal function (CKD Stage ≥2), with vesicoureteral reflux identified as the primary modifiable risk factor. Early VUR detection and aggressive bladder management may preserve long-term kidney function in this complex patient population.

Key takeaways

  • 45.6% of persistent cloaca patients post-PSARUVP develop chronic kidney disease (Stage ≥2), indicating significant long-term renal risk.
  • Vesicoureteral reflux is a key modifiable risk factor—significantly associated with renal function decline, UTIs, and bladder dysfunction.
  • Early VUR assessment and aggressive bladder management are critical to preserving renal function in persistent cloaca patients.
  • Hydrocolpos and renal anomalies show trends toward renal decline, warranting close prenatal and postnatal monitoring.
  • Vesicostomy use correlates with worse renal outcomes, possibly reflecting disease severity rather than causation.

Keywords

Hashtags

Full article text

Full article text not available for this entry
How to cite: GlobalCastMD. The postoperative renal function of persistent cloaca patients treated by posterior sagittal anorecto-urethro-vaginopalsty: results of a nationwide survey in Japan. GlobalCastMD Medical Library. 2024-07-06. https://dev.library.globalcastmd.com/article/8813?via_space=staycurrentmd

Comments

Loading comments...